Publicité
When observing the Instructions for Use and with a vaporization temperature
of 210°C (410°F) the following exemplary reference values are validated for
hemp flowers with a cannabinoid content of e.g. 19% THC and 0% CBD:
Amount of
hemp flowers
(Dosing Cap-
sule content)
50 mg
100 mg
150 mg
Reference values for hemp flowers with a cannabinoid content of e.g. 6% THC
and 7.5% CBD:
Amount of
hemp flow-
ers (Dosing
Capsule
content)
50 mg
100 mg
150 mg
In order to reach these values, inhalation must be continued until there is no
aerosol (vapor) recognizable when exhaling. The Dosing Capsule's content
is then depleted.
X If you have any questions about the medical use of cannabinoids or can-
nabis, contact your doctor, pharmacist or the manufacturers of medical
hemp flowers (Cannabis flos).
X You can find more information about cannabinoids on our homepage:
www.vapormed.com.
© Copyright Gebrauchs.info
4 I M P O R TA N T I N F O R M AT I O N
A B O U T C A N N A B I N O I D
Cannabinoid
content of the
hemp flower
portion
THC: 9.5 mg
THC: 19 mg
THC: 28.5 mg
Cannabinoid
content of the
hemp flower
portion
THC: 3 mg
CBD: approx. 3.2 mg
THC: 6 mg
CBD: approx. 7.5 mg
THC: 9 mg
CBD: approx. 11 mg
Cannabinoid
content in
the aerosol
(vapor)
approx. 5 mg
approx. 9.5 mg
approx. 14 mg
Cannabinoid
content in
the aerosol
(vapor)
approx. 1.5 mg
approx. 1 mg
approx. 1.6 mg
approx. 1.1 mg
approx. 3 mg
approx. 2 mg
approx. 2.3 mg
approx. 3.7 mg
approx. 4.5 mg
approx. 3 mg
approx. 5.5 mg
approx. 3.5 mg
59
Cannabinoid
content in blood
stream (systemic
bioavailability)
after inhalation
approx. 3 mg
approx. 6 mg
approx. 9.5 mg
Cannabinoid
content in blood
stream (systemic
bioavailability)
after inhalation
Publicité
